1. Home
  2. AVNS vs PHAR Comparison

AVNS vs PHAR Comparison

Compare AVNS & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVNS
  • PHAR
  • Stock Information
  • Founded
  • AVNS 2014
  • PHAR 1988
  • Country
  • AVNS United States
  • PHAR Netherlands
  • Employees
  • AVNS N/A
  • PHAR N/A
  • Industry
  • AVNS Industrial Specialties
  • PHAR Biotechnology: Pharmaceutical Preparations
  • Sector
  • AVNS Health Care
  • PHAR Health Care
  • Exchange
  • AVNS Nasdaq
  • PHAR Nasdaq
  • Market Cap
  • AVNS 591.9M
  • PHAR 707.9M
  • IPO Year
  • AVNS N/A
  • PHAR N/A
  • Fundamental
  • Price
  • AVNS $10.99
  • PHAR $10.96
  • Analyst Decision
  • AVNS
  • PHAR Strong Buy
  • Analyst Count
  • AVNS 0
  • PHAR 3
  • Target Price
  • AVNS N/A
  • PHAR $30.00
  • AVG Volume (30 Days)
  • AVNS 435.7K
  • PHAR 5.3K
  • Earning Date
  • AVNS 08-05-2025
  • PHAR 07-31-2025
  • Dividend Yield
  • AVNS N/A
  • PHAR N/A
  • EPS Growth
  • AVNS N/A
  • PHAR N/A
  • EPS
  • AVNS N/A
  • PHAR N/A
  • Revenue
  • AVNS $689,200,000.00
  • PHAR $339,836,000.00
  • Revenue This Year
  • AVNS N/A
  • PHAR $12.88
  • Revenue Next Year
  • AVNS $3.42
  • PHAR $8.54
  • P/E Ratio
  • AVNS N/A
  • PHAR N/A
  • Revenue Growth
  • AVNS 1.34
  • PHAR 22.44
  • 52 Week Low
  • AVNS $10.87
  • PHAR $6.73
  • 52 Week High
  • AVNS $25.36
  • PHAR $12.61
  • Technical
  • Relative Strength Index (RSI)
  • AVNS 34.82
  • PHAR 58.06
  • Support Level
  • AVNS $11.77
  • PHAR $9.54
  • Resistance Level
  • AVNS $12.16
  • PHAR $10.46
  • Average True Range (ATR)
  • AVNS 0.38
  • PHAR 0.37
  • MACD
  • AVNS -0.05
  • PHAR 0.10
  • Stochastic Oscillator
  • AVNS 10.04
  • PHAR 81.20

About AVNS Avanos Medical Inc.

Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

Share on Social Networks: